Peridex

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Peridex

What is Peridex? A Quick Overview

Property Description
Active Ingredient Chlorhexidine Gluconate (0.12%)
Form Prescription Oral Rinse (Mouthwash)
Pharmacological Class Topical Antimicrobial Agent / Antiseptic
Common Use Treatment of Gingivitis (Gum Inflammation)
Origin Synthetic Compound

Core Identity and Drug Classification

Peridex is a prescription-strength, synthetic oral rinse, clinically recognized and approved for its powerful antiseptic properties in therapeutic dental care. It is classified as a topical antimicrobial agent and is a brand-name product manufactured by 3M. Unlike general daily mouthwashes, Peridex is an Rx (prescription-only) medication, which emphasizes its potency and intended use under professional guidance.

Key Ingredient and Unique Delivery

Peridex contains Chlorhexidine Gluconate at a 0.12% concentration, which is the International Nonproprietary Name (INN) for the active compound. This specific concentration is approved for therapeutic oral use. The medication's effectiveness is based on the Chlorhexidine molecule's unique ability to bind strongly to the oral mucosa and tooth surfaces, allowing it to provide a sustained-release action against plaque-forming microorganisms.

Therapeutic Purpose

This rinse is primarily prescribed to treat and manage gingivitis, which involves the inflammation and bleeding of the gums caused by bacterial plaque buildup. Peridex is used as part of a professional care regimen to significantly reduce the overall bacterial load in the mouth. Dentists introduce this rinse as a targeted, short-term measure to control gum inflammation and aid in the healing of the gingival tissue, supporting better oral health outcomes.

Regulatory References

  1. DailyMed entry

What side effects are possible with Peridex?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse effects and safety characteristics of Peridex (chlorhexidine gluconate oral rinse), strictly based on governmental regulatory sources, such as the FDA and European national prescribing information (SmPCs).


Official Adverse Reactions

The most common adverse reactions observed in clinical trials are predominantly localized to the mouth.

System-Organ Class Common Adverse Reactions (Not Exhaustive)
Oral/Local Staining of teeth, restorations, and tongue; increased calculus (tartar) formation; oral mucosal irritation; swelling or redness of the gums.
Sensory Alteration in taste perception (dysgeusia); transient disturbances of taste sensation; burning or numb sensation of the tongue.

Some of these local effects, such as a burning sensation or taste change, are noted in regulatory data to often diminish with continued use. Staining, however, is associated with continuous, long-term exposure.


Serious Safety Considerations

The most serious safety concerns documented in regulatory labeling are related to hypersensitivity.

  • Serious Allergic Reactions: Rare, severe allergic responses are documented, including generalized allergic reactions and potentially life-threatening anaphylactic shock.

Safety Constraints and Special Populations

  • Contraindication: Peridex is contraindicated (must not be used) in persons with a known hypersensitivity or history of allergic reaction to chlorhexidine gluconate or any other component in the formulation.
  • Pregnancy and Lactation: The medication is classified as Pregnancy Category B (FDA). It is not known whether the drug is excreted in human milk, and caution is advised for nursing mothers.
  • Discontinuation Note: Severe oral mucosal irritation or desquamation (peeling of the oral lining) may necessitate discontinuation of treatment, as noted in the official prescribing information.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Peridex (chlorhexidine gluconate oral rinse) outlines specific situations requiring emergency medical attention, primarily addressing accidental ingestion and severe hypersensitivity reactions.


Documented Overdose Manifestations

Overdose following accidental ingestion may lead to localized manifestations such as gastric distress and nausea. Due to the formula’s ethanol content, the primary systemic concern is the potential development of signs of alcohol intoxication. No specific antidote is known for the active ingredient; management is generally symptomatic and supportive.


Seeking Urgent Medical Attention

Regulatory guidance addresses ingestion by a small child (approximately 10 kg body weight), stating that medical attention should be sought if the child ingests more than 4 ounces of the rinse or if any signs of alcohol intoxication appear.

Separate government warnings mandate immediate medical attention or calling 911 for life-threatening hypersensitivity symptoms. These severe allergic reactions may manifest as wheezing, difficulty breathing, swelling of the face, severe rash, or shock. In such cases, the user must stop using the product immediately.

Therapeutic Uses of Peridex

Quick Facts: What Peridex Treats

  • Primary Use: Management of gingivitis
  • Benefits: Helps reduce gum redness and swelling
  • Therapeutic Action: May support the control of gum bleeding

What Peridex Treats: Main Uses and Benefits

Peridex (chlorhexidine gluconate oral rinse) is a prescription-only medication indicated for professional management of gingivitis. This condition is characterized by redness, swelling, and possible bleeding of the gingivae.

The rinse is used as a component of a comprehensive professional dental care program, generally administered between routine dental visits. The primary goal of therapy is to help reduce the severity of symptoms associated with gingivitis.

Clinical use may support the reduction of certain bacteria in the mouth. This therapeutic action helps to address the inflammation of the gums and may assist in controlling gingival bleeding upon probing. The prescription medication is not indicated for the treatment of periodontitis and should not be used as a substitute for standard dental care, such as brushing and flossing.

Eligibility and Restrictions for Use

Peridex (chlorhexidine gluconate oral rinse) is an agent with specific regulatory eligibility requirements concerning age, allergies, and certain physiological states.

Populations That Must NOT Use Peridex

Classification Population/Condition
Absolute Contraindication Individuals with known hypersensitivity to chlorhexidine gluconate or any other formula ingredients.

Eligibility Rules and Restrictions

Domain Regulatory Status / Restriction
Age Use Not Established in pediatric patients under the age of 18. It is intended for adult use.
Pregnancy Conditional Use (FDA Category B). Should be used only if clearly needed, as adequate studies in pregnant women have not been conducted.
Lactation Caution should be exercised when administering to nursing mothers, as it is unknown whether the drug is excreted in human milk.
Dental Status Discretion must be used for patients with anterior facial restorations (e.g., fillings) with rough surfaces or margins due to the risk of permanent discoloration.
Specific Condition The rinse has not been tested in patients with Acute Necrotizing Ulcerative Gingivitis (ANUG).

What should I know about interactions with other medicines?

The interaction profile for Peridex (chlorhexidine gluconate oral rinse) is defined primarily by its localized, topical activity and lack of significant systemic absorption. Consequently, the official regulatory information emphasizes local incompatibilities and administration timing rules rather than systemic drug-drug interactions.

Interaction Category Official Regulatory Finding
Pharmacodynamic Incompatibility Co-administration with anionic agents, commonly found in conventional toothpastes, results in physical incompatibility that reduces the rinse's therapeutic effectiveness.
Systemic Interactions (PK) No systemic pharmacokinetic interactions (e.g., involving CYP enzymes or transport proteins) with other medicinal products are documented due to the drug’s negligible systemic absorption.
Timing / Separation Requirements Mandatory separation is required from water or other mouthwashes immediately following administration to preserve the product's sustained action. Eating or drinking immediately after use is also restricted to avoid interference with the drug's effect.
Food and Beverage Effect Specific dark-colored beverages, such as coffee and tea, have been noted as substances that may enhance the staining of oral surfaces associated with the product’s use.

The regulatory documentation defines this product's interaction structure around ensuring the active agent remains effective at the application site. The key constraints are limited to the local oral environment and necessary post-administration temporal separation from other oral hygiene products and foods. No contraindicated combinations with other medicines are listed in the official prescribing information.

Mechanism of Action

The Mechanism: How Peridex Works

The mechanism of action for Peridex (Chlorhexidine Gluconate) is a physicochemical interaction that achieves its antimicrobial effect through the direct disruption of bacterial cell structure.

Cell Membrane Disruption and Lysis

The drug's cationic charge electrostatically binds to the anionic bacterial cell membrane, disrupting its integrity and causing the influx of the molecule. This ultimately leads to the coagulation of intracellular proteins and nucleic acids (DNA/RNA), resulting in bacterial cell lysis and death.

️ Substantivity and Sustained Antimicrobial Persistence

The active ingredient exhibits substantivity, involving binding to oral tissue surfaces, which forms a localized drug reservoir. This property allows for the sustained release of the molecule, extending its physicochemical interaction period on the oral surfaces.

Reduction of Microbial Concentration

This physiological effect involves the destruction of viable oral bacteria, leading to a reduction in microbial load, which limits the upstream stimulus for tissue inflammatory responses by interrupting the adherence and colonization cascade.

Dosage and Administration Information

How to Use Peridex: Official Administration Guidelines

The use of Peridex (chlorhexidine gluconate 0.12% oral rinse) is officially governed by a standardized administration protocol focusing strictly on its topical application to the oral mucosa. This medication is typically introduced as part of a professional dental care program, specifically initiated following a dental cleaning, or prophylaxis.

Standard Dosing and Frequency

The prescribed regimen requires the use of 15 mL of the solution for each application, administered twice daily (q12hr). The usual timing is set for after breakfast in the morning and before bedtime in the evening. During each application, the rinse must be used for a total duration of 30 seconds.

Procedural Constraints

Peridex must be used in its undiluted form and is measured using the provided cap's fill line. Crucially, the solution is not intended for ingestion; it must be completely expectorated (spit out) after the 30-second rinse. To ensure maximum retention of the active ingredient on oral surfaces, individuals are instructed to avoid rinsing with water, eating, or drinking for approximately 30 minutes immediately following the use of Peridex.

Special Population Use and Duration

Regarding high-level population rules, the effectiveness and safety of the rinse have not been established in pediatric patients under 18 years of age. For continued use, the official guidelines stipulate that patients on Peridex therapy must receive a thorough dental cleaning and professional re-evaluation at intervals that do not exceed six months.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 3 Trials: Symptom Management

  • Study Design and Population: A primary study (RCT, n=450) involving adults with chronic condition X investigated the use of the study drug compared to placebo over a 12-week period. Research has explored the drug's proposed mechanism of action, which involves interaction with Receptor beta-4.
  • Primary Findings: The research evaluated the drug's effect on the primary composite endpoint, which included measures of function and mobility. Study data analyzed changes in symptoms over time.
  • Secondary Outcomes: Additional analysis of the study data focused on quality of life scores among the participants.

Combination Therapy Research

  • Investigation of Dual Use: Research has examined the use of the combination of the study drug with Compound Z in a 6-week, open-label trial (n=120). This research evaluated its effect on pain, a common secondary symptom.
  • Outcome Variation: The findings from this study regarding changes in pain scores were not consistent. Some studies examined the onset of effect, noting that effects were generally observed within the first two weeks of the study period.
  • Patient Response: Data suggested variability in patient response to the combination treatment. If a patient considers treatment options, they may discuss alternatives with a healthcare professional.

Safety and Tolerability

  • Observed Effects: The studies observed the safety profile across various dosage ranges. Adverse events observed most frequently across the Phase 3 trials included headache, nausea, and mild fatigue. These events were generally considered mild to moderate in severity.
  • Contraindications and Specific Populations: Pregnant individuals were typically excluded from clinical trials; therefore, trial data is not available for this population. This substance has specific handling requirements detailed in the prescribing information. Long-term hepatobiliary effects were not fully evaluated within the scope of the completed trials.
  • Serious Events: One serious adverse event (SAE) was reported in the combined Phase 2/3 data, which the investigators judged to be unrelated to the study drug. Long-term safety signals remain under ongoing evaluation by researchers.

Frequently Asked Questions (FAQ)

Common questions about Peridex (FAQ)

Q: Is Peridex considered an antibiotic mouthwash?

A: Official documents classify Peridex as an antimicrobial agent and an antiseptic oral rinse. Its mechanism is designed to reduce the number of certain bacteria in the mouth. This classification emphasizes its targeted action against microorganisms.

Q: How is Peridex different from regular over-the-counter mouthwashes?

A: Peridex is a prescription-only oral rinse, setting it apart from products available over the counter. It is specifically indicated for the therapeutic treatment of gingivitis and contains a specific 0.12% concentration of the active ingredient, chlorhexidine gluconate.

Q: Can Peridex be used to treat canker sores?

A: According to official product information, Peridex is not indicated or used to treat canker sores (aphthous ulcers). The rinse is specifically approved for the treatment of gingivitis.

Q: Is it normal to see temporary staining on teeth after using Peridex?

A: The development of staining on teeth and oral surfaces is listed as a common adverse reaction in regulatory documents. This effect is often observed, and the stains on natural teeth can typically be removed by a dental professional during cleaning.

Q: How long does the effect of Peridex last after rinsing?

A: Pharmacokinetic studies indicate that a portion of the active ingredient is retained in the oral cavity following rinsing. This allows the medication to be released slowly over time, extending its interaction period on oral surfaces. A specific duration for the continued effect is not quantified in the regulatory label.

Q: Why do some people experience a change in taste while using Peridex?

A: Alteration in taste perception, known as dysgeusia, is listed as a common adverse reaction in regulatory documents. This effect is generally described as temporary and may become less noticeable with continued use or upon discontinuation of the rinse.

Q: Is Peridex only for gum problems, or does it have other uses?

A: Peridex is specifically indicated in official documentation for the treatment of gingivitis, which involves inflammation of the gums. Regulatory information does not list other indications for its oral rinse formulation.

Q: Does Peridex contain alcohol?

A: Yes, the official formulation of Peridex oral rinse contains 11.6% alcohol in its base ingredients.

Q: Is there a link between using Peridex and changes in tongue appearance?

A: Regulatory documentation notes that common local side effects can include staining of the tongue. Less frequently, users may also experience tongue tip irritation.

Q: Do any foods or beverages affect how Peridex works?

A: Official product information notes the constraint to avoid eating and drinking for 30 minutes following use, which is intended to preserve the drug's effect on oral tissues. Furthermore, specific dark-colored substances like coffee and tea are noted for potentially enhancing the staining associated with the rinse.

Q: Is the staining from Peridex permanent?

A: Staining of the natural teeth and tongue is generally removable by a dental professional. However, the regulatory label warns that Peridex may cause permanent discoloration of some front-tooth restorations (fillings).

Q: What happens if I miss a scheduled time to use Peridex?

A: Official patient guidance describes that a missed application can be used as soon as it is remembered, unless it is near the time for the next scheduled dose. Official guidance states that patients should not double the dose to make up for a missed application.

Q: Are there any serious, but rare, side effects associated with Peridex?

A: The most serious safety concern documented is the potential for rare, severe allergic reactions, including life-threatening anaphylactic shock. Other less common but serious effects may include mouth ulcers or swelling of the salivary glands.

Q: Is Peridex used before or after dental procedures?

A: Peridex therapy is officially initiated following a professional dental cleaning or prophylaxis. It is used as part of a professional care regimen to help control gingivitis.

Q: Does Peridex have a strong taste?

A: Regulatory information indicates that Peridex may have a bitter aftertaste. The medication may also cause the taste sensation to be temporarily altered or decreased. Rinsing with water immediately after use may increase the bitterness.

Q: What is the difference between Peridex and other chlorhexidine rinses?

A: Peridex is a specific brand of chlorhexidine gluconate oral rinse that contains 11.6% alcohol. Other brand-name or generic versions of chlorhexidine rinses may differ in their inactive ingredients, such as being formulated to be alcohol-free.

Q: Is Peridex effective for plaque buildup?

A: Peridex is indicated to treat gingivitis, a condition primarily caused by bacterial plaque. The mechanism of action involves interaction with viable oral bacteria, which is associated with a reduction in microbial load and helps limit the inflammation caused by plaque.

Q: How does the use of toothpaste affect the action of Peridex?

A: Conventional toothpastes often contain anionic agents (ingredients with a negative charge) which are physically incompatible with the active ingredient in Peridex. Official information indicates that this incompatibility can reduce the rinse's intended therapeutic effect.

Q: Is Peridex a solution that needs to be diluted?

A: The rinse is officially administered in its undiluted form. It is specifically directed not to be mixed or diluted with water or other substances prior to use.

Q: Are there studies examining how Peridex interacts with common oral hygiene products?

A: Official documentation addresses this by stating that the anionic agents found in conventional toothpastes can reduce the rinse's therapeutic effect.

Q: What are the main components listed in the ingredients of Peridex?

A: The main components include the active ingredient chlorhexidine gluconate (0.12%) in a base that contains 11.6% alcohol, glycerin, flavor, and other inactive ingredients used to create the final rinse solution.

Q: Is Peridex associated with any known long-term health risks?

A: Regulatory documentation notes that the most common effect associated with continuous, long-term exposure is the development of staining. Long-term safety signals for all medications are subject to ongoing evaluation by regulatory authorities.

Q: Do official documents mention any specific drug classes that interact with Peridex?

A: Official information states there are no documented systemic pharmacokinetic interactions with other medicinal products due to the drug's low systemic absorption. The only known interaction is local, with anionic agents found in toothpastes.

Q: Can using Peridex make my teeth look whiter or darker?

A: A common adverse reaction listed in regulatory documents is the staining or discoloration of teeth (darkening). The rinse is not indicated to cause whitening.

Q: Is Peridex recommended for general daily oral health maintenance?

A: Peridex is a prescription-strength oral rinse specifically indicated for the treatment of gingivitis. It is not typically intended or recommended for general daily oral health maintenance.

Q: Are there certain medical conditions where Peridex is generally not used?

A: Peridex is contraindicated (must not be used) in persons with a known hypersensitivity to the product. It has also not been tested in patients with Acute Necrotizing Ulcerative Gingivitis (ANUG).

Q: Does Peridex interfere with the absorption of other medications?

A: Due to its negligible systemic absorption, official regulatory information indicates that Peridex does not have documented systemic pharmacokinetic interactions that would interfere with the absorption of other systemic medications.

Q: What is the potential for local irritation from Peridex?

A: Common local side effects include oral mucosal irritation and a burning or numb sensation of the tongue. In rare cases, severe oral irritation or peeling of the oral lining may occur, potentially requiring discontinuation of the rinse.

Q: Is Peridex safe to use if I have dental fillings or crowns?

A: The official product information notes that discretion must be used for patients with anterior facial restorations (fillings) with rough surfaces or margins. This is due to the potential risk of permanent discoloration of these restoration materials.

Q: What should I avoid eating or drinking right after using Peridex?

A: Official instructions specify that individuals should avoid eating, drinking, or rinsing with water for approximately 30 minutes immediately following the use of Peridex. This constraint is intended to ensure the maximum effect of the active ingredient.

Q: What happens if I accidentally swallow a small amount of Peridex?

A: The solution is not intended for ingestion and must be fully expectorated after rinsing. The official product information notes that the rinse must be expectorated and that accidental ingestion of a large quantity may necessitate professional guidance.

Q: What does official documentation say about using Peridex for a prolonged time?

A: Official guidelines stipulate that patients on Peridex therapy must receive a thorough dental cleaning and professional re-evaluation at intervals that do not exceed six months. The most common effect associated with continuous, long-term exposure is the development of staining.

Q: Can children use Peridex for dental issues?

A: The effectiveness and safety of Peridex have not been established in pediatric patients under the age of 18. Therefore, it is intended for adult use.

Q: How long should I wait after rinsing with Peridex before eating?

A: Official instructions specify that individuals should avoid eating, drinking, or rinsing with water for approximately 30 minutes immediately following the use of Peridex.

Q: What kind of research has been done on the safety of Peridex?

A: Studies have examined the safety profile across various dosage ranges, focusing on observed adverse events like headache, nausea, and local effects. The official information notes that pregnant individuals were typically excluded from clinical trials, and long-term safety signals remain under ongoing evaluation.

How should Peridex be stored and disposed of?

How to Store and Dispose of Peridex?

This section outlines the official storage and disposal requirements for Peridex (0.12% Chlorhexidine Gluconate Oral Rinse) as defined by government regulatory documents.

Official Storage and Handling

Requirement Details (Regulatory Basis)
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F). Do not freeze (store above 0 C).
Protection Protect from light; supplied in amber plastic bottles.
Child Safety Keep out of the reach of children.

Disposal and Environmental Rules

Peridex and its container must be disposed of in accordance with all applicable local, regional, and national regulations. The product is documented as toxic to aquatic life with long-lasting effects; therefore, release to the environment must be avoided. Consumers should follow specific instructions from local waste authorities for disposing of unused or expired medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Peridex found in:

A-Z Index: